TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biolin Scientific AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
135,519
|
140,636
|
118,087 |
| Financial expenses |
406
|
473
|
463 |
| Earnings before taxes |
4,076
|
23,845
|
20,775 |
| EBITDA |
10,387
|
27,000
|
26,019 |
| Total assets |
148,624
|
142,530
|
121,915 |
| Current assets |
58,401
|
50,391
|
36,376 |
| Current liabilities |
32,241
|
29,468
|
27,955 |
| Equity capital |
115,355
|
112,032
|
93,137 |
| - share capital |
26,581
|
26,581
|
26,581 |
| Employees (average) |
22
|
24
|
21 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.6%
|
78.6%
|
76.4% |
| Turnover per employee |
6,160
|
5,860
|
5,623 |
| Profit as a percentage of turnover |
3.0%
|
17.0%
|
17.6% |
| Return on assets (ROA) |
3.0%
|
17.1%
|
17.4% |
| Current ratio |
181.1%
|
171.0%
|
130.1% |
| Return on equity (ROE) |
3.5%
|
21.3%
|
22.3% |
| Change turnover |
-5,117
|
22,549
|
11,152 |
| Change turnover % |
-4%
|
19%
|
10% |
| Chg. No. of employees |
-2
|
3
|
-2 |
| Chg. No. of employees % |
-8%
|
14%
|
-9% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.